D
David P. Harrington
Researcher at Harvard University
Publications - 140
Citations - 17404
David P. Harrington is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Covariate. The author has an hindex of 43, co-authored 130 publications receiving 16465 citations. Previous affiliations of David P. Harrington include Beth Israel Deaconess Medical Center & Brown University.
Papers
More filters
Journal ArticleDOI
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
Joan H. Schiller,David P. Harrington,Chandra P. Belani,Corey J. Langer,Alan B. Sandler,James E. Krook,Junming Zhu,David H. Johnson +7 more
TL;DR: None of four chemotherapy regimens offered a significant advantage over the others in the treatment of advanced non-small-cell lung cancer.
Journal ArticleDOI
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
Robert A. Kyle,J. Anthony Child,Kenneth C. Anderson,Bart Barlogie,Régis Bataille,William I. Bensinger,Joan Bladé,Mario Boccadoro,William S. Dalton,Meletios A. Dimopoulos,Benjamin Djulbegovic,Mark T. Drayson,Brian G.M. Durie,Thiery Facon,Rafael Fonseca,Gösta Gahrton,Philip R. Greipp,Jean Luc Harousseau,David P. Harrington,Mohamad A. Hussein,Douglas E. Joshua,Heinz Ludwig,Gareth J. Morgan,Martin M. Oken,R. L. Powles,Paul G. Richardson,David Roodman,Jesús F. San Miguel,Kazuyuki Shimizu,Chaim Shustik,Bhawna Sirohi,Pieter Sonneveld,Guido J Tricot,Ingemar Turesson,Brian G Van Ness,David H. Vesole,Donna M. Weber,Jan Westin,Keith Wheatley +38 more
TL;DR: The International Myeloma Working Group has reviewed the criteria for diagnosis and classification with the aim of producing simple, easily used definitions based on routinely available investigations to facilitate comparison of therapeutic trial data.
Book
Counting Processes and Survival Analysis
TL;DR: The Martingale Central Limit Theorem as mentioned in this paper is a generalization of the central limit theorem of the Counting Process and the Local Square Integrable Martingales (LSIM) framework.
Journal ArticleDOI
Clinical and biologic implications of recurrent genomic aberrations in myeloma
Rafael Fonseca,Emily A. Blood,Montserrat Rué,David P. Harrington,Martin M. Oken,Robert A. Kyle,Gordon W. Dewald,Brian G Van Ness,Scott Van Wier,Kimberly J. Henderson,Richard J. Bailey,Philip R. Greipp +11 more
TL;DR: A stratification of patients into 3 distinct categories allowed for prognostication: poor prognosis group (t(4;14)(p16;q32), t(14; 16)(q32;q23), and - 17p13), intermediate prognosis (- 13q14), and good prognosis groups (all others).
Journal ArticleDOI
Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
Peter A. Cassileth,David P. Harrington,Frederick R. Appelbaum,Hillard M. Lazarus,Jacob M. Rowe,Elisabeth Paietta,Cheryl L. Willman,David D. Hurd,John M. Bennett,Karl G. Blume,David R. Head,Peter H. Wiernik +11 more
TL;DR: A postinduction course of high-dose cytarabine can provide equivalent disease-free survival and somewhat better overall survival than autologous marrow transplantation in adults with acute myeloid leukemia.